mRNA Vaccines against Flaviviruses

被引:29
|
作者
Wollner, Clayton J. [1 ]
Richner, Justin M. [1 ]
机构
[1] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA
关键词
flavivirus; mRNA vaccines; Dengue; Zika; tick-borne encephalitis;
D O I
10.3390/vaccines9020148
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Numerous vaccines have now been developed using the mRNA platform. In this approach, mRNA coding for a viral antigen is in vitro synthesized and injected into the host leading to exogenous protein expression and robust immune responses. Vaccines can be rapidly developed utilizing the mRNA platform in the face of emerging pandemics. Additionally, the mRNA coding region can be easily manipulated to test novel hypotheses in order to combat viral infections which have remained refractory to traditional vaccine approaches. Flaviviruses are a diverse family of viruses that cause widespread disease and have pandemic potential. In this review, we discuss the mRNA vaccines which have been developed against diverse flaviviruses.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 50 条
  • [41] Fight against COVID-19 with mRNA vaccines and interaction with Dermal fillers
    Ghasemi, Shohreh
    Dashti, Mahmood
    CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 2021, 10 (02) : 151 - 153
  • [42] Development of Bivalent mRNA Vaccines against SARS-CoV-2 Variants
    Li, Jianglong
    Liu, Qi
    Liu, Jun
    Fang, Zihui
    Luo, Liping
    Li, Shuang
    Lei, Yixin
    Li, Zhi
    Jin, Jing
    Xie, Ronglin
    Peng, Yucai
    VACCINES, 2022, 10 (11)
  • [43] Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis
    De Voss, Christopher J.
    Korompis, Marcellus
    Li, Shuailin
    Ateere, Alberta
    Mcshane, Helen
    Stylianou, Elena
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [44] Booster vaccination with mRNA vaccines against SARS-CoV-2 virus
    Pecks, Ulrich
    Schleussner, Ekkehard
    Zollkau, Janine
    Scharl, Anton
    Kehl, Sven
    Hagenbeck, Carsten
    Schlembach, Dietmar
    Abou-Dakn, Michael
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (02) : 130 - 130
  • [45] Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
    Zang, Jinkai
    Yin, Yannan
    Xu, Shiqi
    Qiao, Weihua
    Liu, Qiuyue
    Lavillette, Dimitri
    Zhang, Chao
    Wang, Haikun
    Huang, Zhong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [46] mRNA vaccines against COVID-19: a showcase for the importance of microbial biotechnology
    Bruessow, Harald
    MICROBIAL BIOTECHNOLOGY, 2022, 15 (01): : 135 - 148
  • [47] Vaccines against COVID-19: Priority to mRNA-Based Formulations
    Pascolo, Steve
    CELLS, 2021, 10 (10)
  • [48] In Gratitude for mRNA Vaccines
    Phimister, Elizabeth G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (15): : 1436 - 1438
  • [49] Immune mediated and inherited defences against flaviviruses
    Brinton, MA
    Kurane, I
    Mathew, A
    Zeng, LL
    Shi, PY
    Rothman, A
    Ennis, FA
    CLINICAL AND DIAGNOSTIC VIROLOGY, 1998, 10 (2-3): : 129 - 139
  • [50] Oral mRNA Vaccines Against Infectious Diseases- A Bacterial Perspective [Invited]
    Jawalagatti, Vijayakumar
    Kirthika, Perumalraja
    Lee, John Hwa
    FRONTIERS IN IMMUNOLOGY, 2022, 13